Clinical Trial Update: Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy

View source ↗

Summary

This entry notes a completed clinical trial evaluating the dosage, efficacy, and safety of perampanel as monotherapy in patients with epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Generalized Tonic-clonic Seizures
• Partial-onset Seizures

Drugs mentioned

• Fycompa (perampanel)

Snippet

Sponsor: Eisai Inc. | Conditions: Epilepsy, Partial-Onset Seizures | Status: COMPLETED